ImmunoCellular Therapeutics (IMUC) Reports In-Line Q3 EPS

November 10, 2016 4:30 PM EST
Get Alerts IMUC Hot Sheet
Trade IMUC Now!
Join SI Premium – FREE

Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.

ImmunoCellular Therapeutics (NYSE: IMUC) reported Q3 EPS of ($0.04), in-line with the analyst estimate of ($0.04).

For earnings history and earnings-related data on ImmunoCellular Therapeutics (IMUC) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment